Cell type | Subset | Patient 1 | Patient 2 | Normal age-related range (clinical laboratory) |
---|---|---|---|---|
Lymphocytes | Absolute CD3+ | 2394 | 2830 | 850–3200 cells/µL |
Absolute CD3+CD4+ | 1406 | 2065 | 400–2100 cells/µL | |
Absolute CD3+CD8+ | 1178 | 766 | 300–1300 cells/µL | |
CD4+/CD8+ ratio | 1.1 (L) | 2.5 | 1.5–2.5 | |
B cells (CD19+) | 122 | 266 | 120–740 cells/µL | |
% class-switched memory B cells | 2% (L) | 4% (L) | 9–26% | |
NK cells | 1102 (H) | 133 | 7–480 cells/µL | |
CD3+CD4–CD8– alpha/beta | 0.6% | 0.8% | <1.5% | |
 |  |  |  | Normal range * |
CD4+ T cells | CD4+ memory (CD45RO+) | 33.1 | 19.1 (L) | 23.4–66.5 |
CD4+ TEM | 21.5 | 11.4 | 9.1–48.4 | |
CD4+ TCM | 9.0 (H) | 5.3 | 2.1–7.5 | |
CD4+ TEMRA | 2.1 (L) | 1.8 (L) | 3.0–13.6 | |
CD4+ Teff | 0.3 | 0.5 | 0–2.5 | |
CD4+ naïve (CD45RA+) | 59.1 | 74.2 (H) | 21.2–62.7 | |
CD8+ T cells | CD8+ memory (CD45RO+) | 77.3 (H) | 39.4 | 8.2–68.3 |
CD8+ TEM | 30.0 | 14.7 | 0–30.7 | |
CD8+ TCM | 2.6 (H) | 0.7 | 0.1–2.5 | |
CD8+ TEMRA | 43.6 (H) | 20.7 | 8.7–29.0 | |
CD8+ Teff | 2.4 | 2.5 | 0–29.4 | |
CD8+ naïve (CD45RA+) | 15.2 | 54.6 | 8.3–83.9 | |
T follicular cells | CD4+ CXCR5+ | 1.8 (L) | 2.0 (L) | 2.2–9.4 |
CD8+ CXCR5+ | 0.3 | 0.2 | 0–4.4 | |
Treg cells | Total Treg (% of CD4+) | 3.6 | 2.8 | 2.6–6.3 |
Naive Treg (CD45RO–) | 27.1 | 38.9 | 15.1–49.4 | |
Memory Treg (CD45RO+) | 57.2 | 41.8 | 40–82 | |
T cell cytokines | CD4+ TEM IFN-γ+ | 37.5 | 9.3 (L) | 12.8–56.4 |
CD4+ TEM IL-13+ | 3.0 | 6.8 | 2.3–7.0 | |
CD4+ TEM IL-17+ | 1.8 | 2.4 | 1.0–3.2 | |
CD8+ TEM IFN-γ+ | 55.2 | 35.5 (L) | 42.0–100 | |
CD8+ TEM IL-13+ | 0.7 | 0.4 | 0.2–8.1 | |
CD8+ TEM IL-17+ | 1.7 (H) | 1.4 (H) | 0–0.9 | |
Checkpoint molecules | CD4+ TEM CTLA-4+ | 22.4 (L) | 21.2 (L) | 24.5–43.7** |
CD4+ TEM PD-1+ | 58.5 | 44.9 | 26.6–70.3 | |
CD4+ TEM TIM-3+ | 3.7 (H) | 4.8 (H) | 0.4–1.8 | |
Activation marker | CD4+ TEM HLA-DR+ | 20.2 (H) | 10.2 (H) | 1.5–9.4 |
CD8+ TEM HLA-DR+ | 6.3 | 7.5 | 0–22.5 |